CIK: 0001703031
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SWTXUSD | Springworks Therapeutics INC | Stock-Other | 32.35% | — | — | |
| 2 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 10.87% | — | — | |
| 3 | ANNX | Annexon INC | Stock-Other | 9.13% | +0.58% | — | |
| 4 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 6.84% | — | — | |
| 5 | ✓ | Mersana Therapeutics INC | Stock-Other | 5.98% | — | — | |
| 6 | REPL | Replimune Group INC | Stock-Other | 4.55% | — | -1.86% | |
| 7 | DVAX | Dynavax Technologies CORP | Stock-Other | 4.39% | — | — | |
| 8 | NRIX | Nurix Therapeutics INC | Stock-Other | 4.18% | — | — | |
| 9 | SG7 | Sage Therapeutics INC | Stock-Other | 2.84% | — | — | |
| 10 | CNST | Constellation Pharmaceutical | Stock-Other | 2.64% | — | — | |
| 11 | KYMR | Kymera Therapeutics INC | Stock-Other | 2.20% | — | — | |
| 12 | SVRA | Savara INC | Stock-Other | 2.14% | +0.54% | — | |
| 13 | AGLEUSD | Aeglea Biotherapeutics INC | Stock-Other | 1.78% | — | — | |
| 14 | ✓ | Aptinyx INC | Stock-Other | 1.75% | — | — | |
| 15 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 1.71% | — | -75.00% | |
| 16 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 1.56% | — | — | |
| 17 | ✓ | Therapeutics Acquisition Cor | Stock-Other | 1.34% | — | — | |
| 18 | ASNSUSD | X4 Pharmaceuticals INC | Stock-Other | 1.04% | — | — | |
| 19 | ✓ | Arya Sciences Acquisition Co | Stock-Other | 1.01% | — | — | |
| 20 | SLDB | Solid Biosciences Inc. | Stock-Other | 0.73% | — | — | |
| 21 | ✓ | Bctg Acquisition CORP | Stock-Other | 0.48% | — | — | |
| 22 | ✓ | Panacea Acquisition CORP | Stock-Other | 0.47% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SG7 | Sage Therapeutics INC | +0.7% | — | Unchanged |
| 2 | SWTXUSD | Springworks Therapeutics INC | +0.3% | — | Unchanged |
| 3 | MRNSUSD | Marinus Pharmaceuticals INC | +0.2% | -75.00% | Trim |
| 4 | SVRA | Savara INC | -0.3% | — | Unchanged |
| 5 | CRNX | Crinetics Pharmaceuticals In | -0.4% | — | Unchanged |
| 6 | SLDB | Solid Biosciences Inc. | -0.5% | — | Unchanged |
| 7 | ASNSUSD | X4 Pharmaceuticals INC | -0.6% | — | Unchanged |
| 8 | ✓ | Aptinyx INC | -0.7% | — | Unchanged |
| 9 | AGLEUSD | Aeglea Biotherapeutics INC | -0.8% | — | Unchanged |
| 10 | REPL | Replimune Group INC | -1.1% | -1.86% | Trim |
| 11 | ARQT | Arcutis Biotherapeutics INC | -1.7% | — | Unchanged |
| 12 | CNST | Constellation Pharmaceutical | -1.8% | — | Unchanged |
| 13 | ✓ | Mersana Therapeutics INC | -2.5% | — | Unchanged |
| 14 | DRNAUSD | Dicerna Pharmaceuticals INC | -4% | — | Unchanged |
| 15 | DVAX | Dynavax Technologies CORP | -5.7% | — | Unchanged |
| 16 | ANNX | Annexon INC | — | NEW | New buy |
| 17 | NRIX | Nurix Therapeutics INC | — | NEW | New buy |
| 18 | KYMR | Kymera Therapeutics INC | — | NEW | New buy |
| 19 | ✓ | Therapeutics Acquisition Cor | — | NEW | New buy |
| 20 | ✓ | Arya Sciences Acquisition Co | — | NEW | New buy |
| 21 | ✓ | Bctg Acquisition CORP | — | NEW | New buy |
| 22 | ✓ | Panacea Acquisition CORP | — | NEW | New buy |